St. David’s Neonatologists Study on Neonatal Retinopathy
Dr. Jennifer Desireddi, M.D. is a Neonatologist specializing in Neonatal-Perinatal Medicine at St. David’s Medical Center. In her 2018 study, Dr. Desireddi collaborated with Dr. C Armitage Harper, pediatric retinologist from Austin Retina Associates, in understanding the life outcomes of Retinopathy of Prematurity (ROP) among micro-premature infants (birth weight is less than 750 g). The retrospective multicenter study included infants at several intensive care facilities in Central Texas from 2011 to 2016. Dr. Desireddi and her colleagues compared the charts of neonates examined and treated with laser ablation or an FDA approved drug (Intravitreal Ranibizumab) with subsequent laser treatment. Read more about this study.
Additionally, Dr. Desireddi presented two posters at the Pediatric Academic Society Conference in May of 2018. Dr. Desireddi presented “The Surgical Approach to Simple Gastroschisis Affects Hospital Management and Length of Stay.” Dr. Desireddi also presented “A CQI Approach to Improving ELBW nutrition in the First Week of Life,” a collaborative project between Dr. Desireddi and Dr. Monica Shah M.D., a neonatologist practicing at St. David’s Medical Center.
Dr. Shah also presented a poster at the 2018 Vermont Oxford Network Conference (VON) titled “A CQI Approach to Improving ELBW nutrition in the First Week of Life.” Dr. Desireddi supported the important work of two St. David’s Medical Center colleagues – Kay Needles, RN and Allison Brannen, RN on their NICU quality project titled “A CQI Approach to Increasing Breastfeeding Rates at Discharge and Reducing the use of Donor Breast Milk” which was presented as a poster at the 2018 VON Conference.
St. David’s Research Scientist, Dr. Max Shpak, Presents on Advances in Cancer Genomics